[Long-term interferon therapy. Effectiveness in multiple sclerosis continues].
D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000008:administration & dosage* / Q000009:adverse effects; D008134:Long-Term Care; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a
Interferon-Langzeittherapie. Nutzen bei Multipler Sklerose bleibt.